The Sputnik V COVID-19 vaccine uses two different adenoviruses as the viral vectors | Each of the two doses uses a different type of adenovirus: first dose with type-26 Ad26 , then a booster dose with type-5 Ad5 |
---|---|
Though the EMA has already launched its rolling review of Sputnik V, it will only be able to begin the approval process after the first results of scientific and clinical trials have been evaluated | Visit our and follow our for the most recent information on the COVID-19 pandemic |
When used in vaccines, adenoviruses are altered to remove their ability to replicate.
Russia will have got there first," said Kirill Dmitriev, head of Russia's sovereign wealth fund, which is financing Russian vaccine production, referring to the successful 1957 launch of the world's first satellite by the Soviet Union | Gamaleya Research Center has recently received an international patent for Ebola vaccine using adenovirus vector |
---|---|
This is his story: I was actually feeling fine before my antibody test | The Czech Republic, Germany and Austria are trying to secure doses of Sputnik V, but have insisted the vaccine will only be used after the EMA gives the go-ahead |
The adenoviruses are weakened so they cannot replicate in humans and cannot cause disease.
14